# US 2020/0206383 A1 · Agent for biological damage repair or hemostasis and the method thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0206383 A1
- Document ID: US20200206383A1
- Status: Published application
- Kind: A1
- Application number: 16/815,291
- Filed: 2020-03-11
- Published: 2020-07-02
- Earliest claimed: 2017-09-15
- Assignees: Haining Zhuluoji Biotechnology Co., Ltd.
- Applicants: Haining Zhuluoji Biotechnology Co., Ltd.
- Inventors: Hongwei Ouyang; Yi Hong; Feifei Zhou; Shufang Zhang
- Web page: https://patentgrep.com/patent/US20200206383A1

## CPC

- A61L 24/043: {Mixtures of macromolecular materials}
- A61L 24/104: {Gelatin}
- A61L 24/08: Polysaccharides {(A61L24/043 takes precedence)}
- C07K 14/43518: {from spiders}
- C07K 14/78: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- C08L 1/286: {substituted with acid radicals, e.g. carboxymethyl cellulose [CMC] (C08L1/282 takes precedence)}
- C08L 5/04: Alginic acid; Derivatives thereof
- C08L 5/08: Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- A61L 2400/04: Materials for stopping bleeding
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- C08L 2312/00: Crosslinking
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

The purpose of the present invention is to provide a light control agent and explore its application, and is expected to improve the tissue binding force and convenience of the existing biological glue material by providing a new reagent or material for biological damage or homeostasis. In one of embodiment, this invention provides an agent for repairing biological damage or homeostasis, wherein the agent comprises a natural biological macromolecule modified by the photo-responsive cross-linking group.

## Claims

### Claim 1

An agent for repairing biological damage or homeostasis, wherein the agent comprises a natural biological macromolecule modified by the photo-responsive cross-linking group; a natural biological macromolecule modified with photo triggered o-nitrobenzyl groups; a photo initiator and/or deionized water.

### Claim 2 (depends on 1)

The reagent of claim 1, wherein the final concentration of the natural biological macromolecule modified by the light-responsive cross-linking group is 0.1 to 10% based on the mass of the deionized water.

### Claim 3 (depends on 2)

The reagent of claim 2, wherein the final concentration of natural biological macromolecules modified by the photo triggered o-nitrobenzyl group is 0.1-10% based on the mass of the deionized water.

### Claim 4 (depends on 3)

The reagent of claim 3, wherein the final mass concentration of the photo initiator is from 0.001 to 1% based on the mass of the deionized water.

### Claim 5 (depends on 2)

The reagent of claim 2, wherein the light-responsive cross-linking group-modified natural biological macromolecule has a graft substitution rate of 10-90% of the photo-responsive cross-linking group.

### Claim 6 (depends on 2)

The reagent of claim 2, wherein the light-responsive cross-linking group is methacrylamide or methacrylic anhydride.

### Claim 7 (depends on 3)

The reagent of claim 3, wherein the o-nitrobenzyl type photo initiator in the o-nitrobenzyl type photo initiator-modified natural bio-macromolecule has a graft substitution rate of 1-100%.

### Claim 8 (depends on 2)

The reagent of claim 2, wherein the photo-reactive cross-linking group in the photo-reactive cross-linking group-modified natural biological macromolecule has a graft substitution rate of 5 to 90%.

### Claim 9 (depends on 2)

The reagent of claim 2, wherein the light-responsive cross-linking group-modified natural bio-macromolecule is methacrylic anhydride-modified gelatin with a graft substitution rate of 10% and the graft substitution rate is 90% Of methacrylamide-modified gelatin, methacrylic anhydride-modified gelatin with a graft substitution of 40%, methacrylamide-modified gelatin with a substitution of 20%, gelatin with a graft substitution of 30% Methacrylic anhydride-modified collagen, methacrylic anhydride-modified chondroitin sulfate with a graft substitution rate of 90%, or methacrylamide-modified carboxymethylcellulose with a graft substitution rate of 10%, or a mixture comprised by several kinds of them.

### Claim 10 (depends on 3)

The reagent of claim 3, wherein the o-nitrobenzyl type photo initiator modified natural biological macromolecule is o-nitrobenzyl modified hyaluronic acid with graft substitution rate of 100% O-nitrobenzyl-modified sodium alginate with a substitution rate of 50%, o-nitrobenzyl modified chondroitin sulfate with a substitution rate of 10%, o-nitrobenzyl with a substitution rate of 30% Modified gelatin, o-nitrobenzyl modified silk fibroin with graft substitution rate of 90%, o-nitrobenzyl modified collagen with graft substitution rate of 100% or o-nitro group with 10% graft substitution Benzyl-modified chitosan in one or a mixture comprised by several kinds of them.

### Claim 11 (depends on 1)

The reagent of claim 1, wherein the natural biological macromolecule in the natural biological macromolecule is hyaluronic acid, gelatin, sodium alginate, chondroitin sulfate, silk fibroin, chitosan Sugar, carboxymethyl cellulose or collagen, or a mixture comprised by several kinds of them.

### Claim 12 (depends on 11)

The reagent of claim 11, wherein the photo initiator is 2-hydroxy-4 (2-hydroxyethoxy)-2-methylpropiophenone or phenyl 6-trimethylbenzoyl) phosphate lithium salt.

### Claim 13

A method of homeostasis in a living organism comprising:
providing an agent comprising a native biological macromolecule modified by a photo-responsive cross-linking group; a natural biological macromolecule modified with an o-nitrobenzyl type photo trigger; a photo initiator and/or deionized water; contacting the agent with bleeding sites, and then light.

### Claim 14 (depends on 13)

The method of claim 13, wherein the irradiation is light irradiation with a wavelength band of 350 to 450 nm and an energy density of 20 to 150 mW/cm2.

### Claim 15 (depends on 14)

The method of claim 14, wherein the irradiation time is 1 to 10 s.

### Claim 16 (depends on 13)

The method of claim 13, wherein the light-responsive cross-linked group-modified native biological macromolecule final concentration is 0.1-10% based on the mass of the deionized water.

### Claim 17 (depends on 16)

The method of claim 16, wherein the o-nitrobenzyl type photo trigger is modified to have a final native biological macromolecule concentration of 0.1% to 10% based on the mass of the deionized water.

### Claim 18 (depends on 13)

The method of claim 13, wherein the photo initiator mass final concentration is 0.001-1% based on the mass of deionized water.

### Claim 19 (depends on 18)

The method of claim 18, wherein the light-responsive cross-linking group-modified natural biological macromolecule has a graft substitution rate of 10-90% of the photo-responsive cross-linking group.

### Claim 20 (depends on 19)

The method of claim 19, wherein the light responsive cross-linking group is methacrylamide or methacrylic anhydride.
